This contract intends to build the reserve of manufacturing capacities to produce one or several Covid-19 therapeutics or late stage development (or other identified and justified need) of one or several Covid-19 therapeutics.

Both options will provide priority access to the therapeutic(s).

The reason for purchasing and expected result of this service contract is to improve access to Covid-19 therapeutics at Union level.

Extended TitleService Contract for Flexible EU Manufacturing and Access of Covid-19 Therapeutics
Extended Description

Service contract for the reserve of manufacturing capacities to produce one or several Covid-19 therapeutics or late stage development (or other identified and justified need) for one or several Covid-19 therapeutic

Publication Date2021-08-03
CountryBelgium
Procurement StatusFuture
TypeNot applicable
Contract TypeServices
Award CriteriaNot applicable
Value37000000.00
OrganisationEuropean Health and Digital Executive Agency (HaDEA), HADEA.A — Health and Food
AddressCOV2, Place Charles Rogier 16
TownBrussels
Postal CodeB-1210
Class Code73000000
Class DescriptionResearch and development services and related consultancy services
SourceOffice for Official Publications of the European Communities - Tenders electronic daily (Ted)

Related Procurements

Deadline: Nov 22, 2021
The purpose of this call for tenders is to establish a framework contract with one supplier for audio-visual services to cover the needs of the Council of the European Union/...
View more
The COVID-19 pandemic showed the challenges for existing EU facilities to ramp-up their production. Thus, as part of strengthening the Health Union, for future health crises the EU must be...
View more
Deadline: Oct 19, 2021
Due to a comprehensive agenda for structural and administrative reforms and the technical assistance needs of the Croatian authorities, DG REFORM has established a dedicated office in Zagreb. The office...
View more